Cornelia Steinert

Title: Cornelia Steinert: Innovator in Immunological Assays

Introduction

Cornelia Steinert is a prominent inventor based in Frankfurt am Main, Germany. She has made significant contributions to the field of immunology, particularly in the development of assays for detecting impurities in human insulin. With a total of 3 patents, her work has had a notable impact on medical diagnostics.

Latest Patents

Steinert's latest patents include an immunologic assay designed to determine C-peptide containing impurities in samples of human insulin and its derivatives. This invention relates to a non-radioactive process for detecting or determining C-peptide-containing impurities in recombinantly produced human insulin. Another significant patent involves monoclonal antibodies for the selective immunological determination of high molecular weight, intact laminin forms in body fluids. This invention focuses on the preparation of these antibodies and their application in diagnosing diseases, specifically targeting intact, native laminin structures.

Career Highlights

Throughout her career, Cornelia Steinert has worked with notable companies such as Hoechst Aktiengesellschaft and Sanofi-Aventis Deutschland GmbH. Her experience in these organizations has contributed to her expertise in immunological research and development.

Collaborations

Steinert has collaborated with esteemed colleagues, including Martin Gerl and Manfred Quint. These partnerships have further enhanced her research and innovation in the field.

Conclusion

Cornelia Steinert's contributions to immunological assays and her innovative patents underscore her role as a leading inventor in her field. Her work continues to influence medical diagnostics and improve patient care.